Let's assume we get to January 09 and EPCT has a partner and releases initial estimates of $120 million in 1st year Ceplene sales with a favorable EPCT royalty/license arrangement. Assuming all other variables in their pipeline remain as they are now (no additional info on Azixa/NP1 etc.), would this change your $1.85-$2.45 estimate?
Manowar, IMO in face of all the given circumstances and the existing asset and license aggreements, and in comparison with similar companies, the current minimum mkt.cap should be at least 160-180 MM, i.e. a fair market price of these shares should be at least 1,85-2,45 p.s. Everything below this range appears to me manipulation.